{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T19:29:17Z","timestamp":1791314957715,"version":"4.3.1"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,28]],"date-time":"2021-09-28T00:00:00Z","timestamp":1632787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,9,28]],"date-time":"2021-09-28T00:00:00Z","timestamp":1632787200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003819","name":"Natural Science Foundation of Hubei Province","doi-asserted-by":"publisher","award":["2020CFB720"],"award-info":[{"award-number":["2020CFB720"]}],"id":[{"id":"10.13039\/501100003819","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Hubei Province health and family planning scientific research project","award":["WJ2019F085"],"award-info":[{"award-number":["WJ2019F085"]}]},{"name":"xiangyang science and technology planning project","award":["2020YL34"],"award-info":[{"award-number":["2020YL34"]}]},{"name":"xiangyang science and technology planning project","award":["2020YL35"],"award-info":[{"award-number":["2020YL35"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Aortic aneurysm (AA) and aortic dissection (AD) are major life-threatening diseases around the world. AA is a localized or diffuse dilation of the aorta, while AD is the separation of the layers creating a false lumen within the aortic wall. Fluoroquinolones (FQ) remain one of the most important kind of antibiotics and have a wider clinical use and broad antibacterial spectrum. FQ were also reported to treat infected AA. The most common adverse events (AEs) of FQ are mild and reversible, like headaches, diarrhea and nausea. Due to FQ-related serious AEs, such as tendonitis and tendon rupture, chondrotoxicity, or retinal detachment, QT-prolongation and dysglycemia, the United States Food and Drug Administration (FDA) issued a black box warning for FQ for systemic use in 2016 and updated warnings for FQ several times since then. Of note, in December 2018, FDA issued several \u201cblack box warnings\u201d against FQ with the latest safety announcement warning about an increased risk of ruptures in the aorta blood vessel in certain patients. Recently, many studies have indicated an association between FQ and an increase risk of AA and AD. However, the exact mechanism of FQ-induced AA\/AD remains unclear. This review aims to highlight the latest research progress of the alarming association between FQ and AA\/AD. Moreover, molecular mechanisms of FQ in increasing risk of AA and AD are explored. Hopefully, this review can provide novel insights into FQ-increased the risk of AA\/AD and a starting place for stewardship interventions.<\/jats:p>","DOI":"10.1186\/s12872-021-02258-1","type":"journal-article","created":{"date-parts":[[2021,9,28]],"date-time":"2021-09-28T11:06:44Z","timestamp":1632827204000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Current progress of fluoroquinolones-increased risk of aortic aneurysm and dissection"],"prefix":"10.1186","volume":"21","author":[{"given":"Cui","family":"Jun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8299-2263","authenticated-orcid":false,"given":"Bian","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,28]]},"reference":[{"issue":"11","key":"2258_CR1","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1001\/jamainternmed.2015.5389","volume":"175","author":"CC Lee","year":"2015","unstructured":"Lee CC, Lee MT, Chen YS, Lee SH, Chen SC, Chang SC. Risk of aortic dissection and aortic aneurysm in patients taking oral fluoroquinolone. JAMA Intern Med. 2015;175(11):1839\u201347.","journal-title":"JAMA Intern Med"},{"issue":"20","key":"2258_CR2","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1161\/CIRCULATIONAHA.112.000483","volume":"127","author":"DP Howard","year":"2013","unstructured":"Howard DP, Banerjee A, Fairhead JF, Perkins J, Silver LE, Rothwell PM. Population-based study of incidence and outcome of acute aortic dissection and premorbid risk factor control: 10-year results from the Oxford Vascular Study. Circulation. 2013;127(20):2031\u20137.","journal-title":"Circulation"},{"issue":"41","key":"2258_CR3","doi-asserted-by":"publisher","first-page":"e1716","DOI":"10.1097\/MD.0000000000001716","volume":"94","author":"SW Wang","year":"2015","unstructured":"Wang SW, Huang YB, Huang JW, Chiu CC, Lai WT, Chen CY. Epidemiology, clinical features, and prescribing patterns of aortic aneurysm in Asian population from 2005 to 2011. Medicine. 2015;94(41):e1716.","journal-title":"Medicine"},{"issue":"12","key":"2258_CR4","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1016\/j.jacc.2018.06.067","volume":"72","author":"CC Lee","year":"2018","unstructured":"Lee CC, Lee MG, Hsieh R, Porta L, Lee WC, Lee SH, Chang SS. Oral fluoroquinolone and the risk of aortic dissection. J Am Coll Cardiol. 2018;72(12):1369\u201378.","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"2258_CR5","doi-asserted-by":"publisher","first-page":"e001926","DOI":"10.1161\/JAHA.115.001926","volume":"4","author":"DP Howard","year":"2015","unstructured":"Howard DP, Banerjee A, Fairhead JF, Handa A, Silver LE, Rothwell PM. Population-based study of incidence of acute abdominal aortic aneurysms with projected impact of screening strategy. J Am Heart Assoc. 2015;4(8):e001926.","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"2258_CR6","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.gheart.2013.12.010","volume":"9","author":"UK Sampson","year":"2014","unstructured":"Sampson UK, Norman PE, Fowkes FG, Aboyans V, Yanna S, Harrell FE Jr, Forouzanfar MH, Naghavi M, Denenberg JO, McDermott MM, Criqui MH, Mensah GA, Ezzati M, Murray C. Global and regional burden of aortic dissection and aneurysms: mortality trends in 21 world regions, 1990 to 2010. Glob Heart. 2014;9(1):171-80e10.","journal-title":"Glob Heart"},{"issue":"25","key":"2258_CR7","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1161\/CIRCULATIONAHA.114.010890","volume":"130","author":"D Sidloff","year":"2014","unstructured":"Sidloff D, Choke E, Stather P, Bown M, Thompson J, Sayers R. Mortality from thoracic aortic diseases and associations with cardiovascular risk factors. Circulation. 2014;130(25):2287\u201394.","journal-title":"Circulation"},{"issue":"2","key":"2258_CR8","doi-asserted-by":"publisher","first-page":"e01712-18","DOI":"10.1128\/AAC.01712-18","volume":"63","author":"WC Frankel","year":"2019","unstructured":"Frankel WC, Trautner BW, Spiegelman A, Grigoryan L, LeMaire SA. Patients at risk for aortic rupture often exposed to fluoroquinolones during hospitalization. Antimicrob Agents Chemother. 2019;63(2):e01712-18.","journal-title":"Antimicrob Agents Chemother"},{"key":"2258_CR9","doi-asserted-by":"publisher","first-page":"k678","DOI":"10.1136\/bmj.k678","volume":"360","author":"B Pasternak","year":"2018","unstructured":"Pasternak B, Inghammar M, Svanstrom H. Fluoroquinolone use and risk of aortic aneurysm and dissection: nationwide cohort study. BMJ. 2018;360:k678.","journal-title":"BMJ"},{"issue":"3","key":"2258_CR10","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.amjmed.2004.09.015","volume":"118","author":"JA Linder","year":"2005","unstructured":"Linder JA, Huang ES, Steinman MA, Gonzales R, Stafford RS. Fluoroquinolone prescribing in the United States: 1995 to 2002. Am J Med. 2005;118(3):259\u201368.","journal-title":"Am J Med"},{"issue":"5","key":"2258_CR11","doi-asserted-by":"publisher","first-page":"e1034","DOI":"10.1542\/peds.2016-2706","volume":"138","author":"MA Jackson","year":"2016","unstructured":"Jackson MA, Schutze GE. The use of systemic and topical fluoroquinolones. Pediatrics. 2016;138(5):e1034\u201345.","journal-title":"Pediatrics"},{"key":"2258_CR12","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1007\/s40264-019-00828-z","volume":"42","author":"X Yu","year":"2019","unstructured":"Yu X, Jiang DS, Wang J, Wang R, Chen T, Wang K, Cao S, Wei X. Fluoroquinolone use and the risk of collagen-associated adverse events: a systematic review and meta-analysis. Drug Saf. 2019;42:1025\u201333.","journal-title":"Drug Saf"},{"issue":"9","key":"2258_CR13","doi-asserted-by":"publisher","first-page":"e1800141","DOI":"10.1002\/ardp.201800141","volume":"351","author":"HAA Ezelarab","year":"2018","unstructured":"Ezelarab HAA, Abbas SH, Hassan HA, Abuo-Rahma GEA. Recent updates of fluoroquinolones as antibacterial agents. Arch Pharm. 2018;351(9):e1800141.","journal-title":"Arch Pharm"},{"issue":"11","key":"2258_CR14","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1086\/430066","volume":"40","author":"PC Drobac","year":"2005","unstructured":"Drobac PC, del Castillo H, Sweetland A, Anca G, Joseph JK, Furin J, Shin S. Treatment of multidrug-resistant tuberculosis during pregnancy: long-term follow-up of 6 children with intrauterine exposure to second-line agents. Clin Infect Dis Off Publ Infect Dis Soc Am. 2005;40(11):1689\u201392.","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"issue":"8","key":"2258_CR15","doi-asserted-by":"publisher","first-page":"2496","DOI":"10.1016\/j.bmc.2014.02.046","volume":"22","author":"M Pudlo","year":"2014","unstructured":"Pudlo M, Luzet V, Ismaili L, Tomassoli I, Iutzeler A, Refouvelet B. Quinolone-benzylpiperidine derivatives as novel acetylcholinesterase inhibitor and antioxidant hybrids for Alzheimer disease. Bioorg Med Chem. 2014;22(8):2496\u2013507.","journal-title":"Bioorg Med Chem"},{"key":"2258_CR16","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.ejmech.2013.08.040","volume":"69","author":"M Abdel-Aziz","year":"2013","unstructured":"Abdel-Aziz M, Park SE, Abuo-Rahma Gel D, Sayed MA, Kwon Y. Novel N-4-piperazinyl-ciprofloxacin-chalcone hybrids: synthesis, physicochemical properties, anticancer and topoisomerase I and II inhibitory activity. Eur J Med Chem. 2013;69:427\u201338.","journal-title":"Eur J Med Chem"},{"key":"2258_CR17","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.jmgm.2013.07.004","volume":"44","author":"J Li","year":"2013","unstructured":"Li J, Li S, Bai C, Liu H, Gramatica P. Structural requirements of 3-carboxyl-4(1H)-quinolones as potential antimalarials from 2D and 3D QSAR analysis. J Mol Graph Model. 2013;44:266\u201377.","journal-title":"J Mol Graph Model"},{"issue":"2","key":"2258_CR18","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1128\/AAC.00414-06","volume":"51","author":"RK Shandil","year":"2007","unstructured":"Shandil RK, Jayaram R, Kaur P, Gaonkar S, Suresh BL, Mahesh BN, Jayashree R, Nandi V, Bharath S, Balasubramanian V. Moxifloxacin, ofloxacin, sparfloxacin, and ciprofloxacin against Mycobacterium tuberculosis: evaluation of in vitro and pharmacodynamic indices that best predict in vivo efficacy. Antimicrob Agents Chemother. 2007;51(2):576\u201382.","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"2258_CR19","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s00894-009-0549-3","volume":"16","author":"M Koba","year":"2010","unstructured":"Koba M, Baczek T, Macur K, Bober L, Frackowiak T, Bucinski A, Rystok-Grabska D, Stasiak J, Koba K. Factor analysis of microbiological activity data and structural parameters of antibacterial quinolones. J Mol Model. 2010;16(2):327\u201335.","journal-title":"J Mol Model"},{"issue":"143","key":"2258_CR20","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1016\/j.ejmech.2017.11.082","volume":"1","author":"GF Zhang","year":"2018","unstructured":"Zhang GF, Zhang S, Pan B, Liu X, Feng LS. 4-Quinolone derivatives and their activities against Gram positive pathogens. Eur J Med Chem. 2018;1(143):710\u201323.","journal-title":"Eur J Med Chem"},{"issue":"12","key":"2258_CR21","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.3201\/eid0912.030169","volume":"9","author":"NT Lan","year":"2003","unstructured":"Lan NT, Lien HT, le Tung B, Borgdorff MW, Kremer K, van Soolingen D. Mycobacterium tuberculosis Beijing genotype and risk for treatment failure and relapse, Vietnam. Emerg Infect Dis. 2003;9(12):1633\u20135.","journal-title":"Emerg Infect Dis"},{"issue":"146","key":"2258_CR22","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.ejmech.2018.01.078","volume":"25","author":"GF Zhang","year":"2018","unstructured":"Zhang GF, Liu X, Zhang S, Pan B, Liu ML. Ciprofloxacin derivatives and their antibacterial activities. Eur J Med Chem. 2018;25(146):599\u2013612.","journal-title":"Eur J Med Chem"},{"issue":"5","key":"2258_CR23","doi-asserted-by":"publisher","first-page":"353","DOI":"10.2165\/11536360-000000000-00000","volume":"33","author":"HH Liu","year":"2010","unstructured":"Liu HH. Safety profile of the fluoroquinolones: focus on levofloxacin. Drug Saf. 2010;33(5):353\u201369.","journal-title":"Drug Saf"},{"issue":"4","key":"2258_CR24","doi-asserted-by":"publisher","first-page":"e0216029","DOI":"10.1371\/journal.pone.0216029","volume":"14","author":"LSM Kuula","year":"2019","unstructured":"Kuula LSM, Viljemaa KM, Backman JT, Blom M. Fluoroquinolone-related adverse events resulting in health service use and costs: a systematic review. PLoS ONE. 2019;14(4):e0216029.","journal-title":"PLoS ONE"},{"issue":"4","key":"2258_CR25","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/s40264-018-0751-2","volume":"42","author":"E Gorelik","year":"2019","unstructured":"Gorelik E, Masarwa R, Perlman A, Rotshild V, Abbasi M, Muszkat M, Matok I. Fluoroquinolones and cardiovascular risk: a systematic review, meta-analysis and network meta-analysis. Drug Saf. 2019;42(4):529\u201338.","journal-title":"Drug Saf"},{"issue":"14","key":"2258_CR26","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1136\/heartjnl-2013-303654","volume":"99","author":"C Olsson","year":"2013","unstructured":"Olsson C, Granath F, Stahle E. Family history, comorbidity and risk of thoracic aortic disease: a population-based case-control study. Heart. 2013;99(14):1030\u20133.","journal-title":"Heart"},{"key":"2258_CR27","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.matbio.2018.04.005","volume":"71\u201372","author":"CJ Lin","year":"2018","unstructured":"Lin CJ, Lin CY, Stitziel NO. Genetics of the extracellular matrix in aortic aneurysmal diseases. Matrix Biol J Int Soc Matrix Biol. 2018;71\u201372:128\u201343.","journal-title":"Matrix Biol J Int Soc Matrix Biol"},{"issue":"16","key":"2258_CR28","doi-asserted-by":"publisher","first-page":"2202","DOI":"10.1161\/CIRCULATIONAHA.108.817619","volume":"119","author":"SH Forsdahl","year":"2009","unstructured":"Forsdahl SH, Singh K, Solberg S, Jacobsen BK. Risk factors for abdominal aortic aneurysms: a 7-year prospective study: the Tromso Study, 1994\u20132001. Circulation. 2009;119(16):2202\u20138.","journal-title":"Circulation"},{"issue":"1","key":"2258_CR29","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jvs.2008.08.012","volume":"49","author":"E Larsson","year":"2009","unstructured":"Larsson E, Granath F, Swedenborg J, Hultgren R. A population-based case-control study of the familial risk of abdominal aortic aneurysm. J Vasc Surg. 2009;49(1):47\u201350 (discussion 1).","journal-title":"J Vasc Surg"},{"issue":"23","key":"2258_CR30","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1161\/CIRCULATIONAHA.117.030972","volume":"136","author":"Q Wang","year":"2017","unstructured":"Wang Q, Ding Y, Song P, Zhu H, Okon I, Ding YN, Chen HZ, Liu DP, Zou MH. Tryptophan-derived 3-hydroxyanthranilic acid contributes to angiotensin II-induced abdominal aortic aneurysm formation in mice in vivo. Circulation. 2017;136(23):2271\u201383.","journal-title":"Circulation"},{"issue":"6","key":"2258_CR31","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1053\/hupa.2000.7642","volume":"31","author":"T Ishii","year":"2000","unstructured":"Ishii T, Asuwa N. Collagen and elastin degradation by matrix metalloproteinases and tissue inhibitors of matrix metalloproteinase in aortic dissection. Hum Pathol. 2000;31(6):640\u20136.","journal-title":"Hum Pathol"},{"issue":"31","key":"2258_CR32","doi-asserted-by":"publisher","first-page":"8759","DOI":"10.1073\/pnas.1601442113","volume":"113","author":"VS Lee","year":"2016","unstructured":"Lee VS, Halabi CM, Hoffman EP, Carmichael N, Leshchiner I, Lian CG, Bierhals AJ, Vuzman D, Mecham RP, Frank NY, Stitziel NO. Loss of function mutation in LOX causes thoracic aortic aneurysm and dissection in humans. Proc Natl Acad Sci USA. 2016;113(31):8759\u201364.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2258_CR33","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2174\/1871525717666190402121958","volume":"17","author":"P Rawla","year":"2019","unstructured":"Rawla P, Helou MLE, Vellipuram AR. Fluoroquinolones and the risk of aortic aneurysm or aortic dissection: a systematic review and meta-analysis. Cardiovasc Hematol Agents Med Chem. 2019;17:3\u201310.","journal-title":"Cardiovasc Hematol Agents Med Chem"},{"issue":"12","key":"2258_CR34","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1016\/j.amjmed.2017.06.029","volume":"130","author":"S Singh","year":"2017","unstructured":"Singh S, Nautiyal A. Aortic dissection and aortic aneurysms associated with fluoroquinolones: a systematic review and meta-analysis. Am J Med. 2017;130(12):1449\u201357.","journal-title":"Am J Med"},{"issue":"274","key":"2258_CR35","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.ijcard.2018.09.067","volume":"1","author":"AT Noman","year":"2019","unstructured":"Noman AT, Qazi AH, Alqasrawi M, Ayinde H, Tleyjeh IM, Lindower P, Bin Abdulhak AA. Fluoroquinolones and the risk of aortopathy: a systematic review and meta-analysis. Int J Cardiol. 2019;1(274):299\u2013302.","journal-title":"Int J Cardiol"},{"key":"2258_CR36","doi-asserted-by":"crossref","unstructured":"Vouga Ribeiro N, Gouveia Melo R, Guerra NC, Nobre \u00c2, Fernandes RM, Pedro LM, Costa J, Pinto FJ, Caldeira D. Fluoroquinolones are associated with increased risk of aortic aneurysm or dissection: systematic review and meta-analysis. Semin Thorac Cardiovasc Surg. 2020.","DOI":"10.1053\/j.semtcvs.2020.11.011"},{"issue":"1","key":"2258_CR37","first-page":"1","volume":"201","author":"XC Dai","year":"2020","unstructured":"Dai XC, Yang XX, Ma L, Tang GM, Pan YY, Hu HL. Relationship between fluoroquinolones and the risk of aortic diseases: a meta-analysis of observational studies. BMC Cardiovasc Disord. 2020;201(1):1\u20138.","journal-title":"BMC Cardiovasc Disord"},{"issue":"1","key":"2258_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-021-90692-8","volume":"11","author":"I Wee","year":"2021","unstructured":"Wee I, Chin B, Syn N, et al. The association between fluoroquinolones and aortic dissection and aortic aneurysms: a systematic review and meta-analysis. Sci Rep. 2021;11(1):1\u201311.","journal-title":"Sci Rep"},{"issue":"6","key":"2258_CR39","doi-asserted-by":"crossref","first-page":"e00664","DOI":"10.1002\/prp2.664","volume":"86","author":"SL Aspinall","year":"2020","unstructured":"Aspinall SL, Sylvain NP, Zhao X, Zhang R, Dong D, Echevarria K, Glassman PA, Goetz MB, Miller DR, Cunningham FE. Serious cardiovascular adverse events with fluoroquinolones versus other antibiotics: a self-controlled case series analysis. Pharmacol Res Perspect. 2020;86(6):e00664.","journal-title":"Pharmacol Res Perspect"},{"issue":"11","key":"2258_CR40","doi-asserted-by":"publisher","first-page":"e010077","DOI":"10.1136\/bmjopen-2015-010077","volume":"5","author":"N Daneman","year":"2015","unstructured":"Daneman N, Lu H, Redelmeier DA. Fluoroquinolones and collagen associated severe adverse events: a longitudinal cohort study. BMJ Open. 2015;5(11):e010077.","journal-title":"BMJ Open"},{"key":"2258_CR41","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1001\/jamasurg.2020.6165","volume":"156","author":"ER Newton","year":"2021","unstructured":"Newton ER, Akerman AW, Strassle PD, Kibbe MR. Association of fluoroquinolone use with short-term risk of development of aortic aneurysm. JAMA Surg. 2021;156:264\u201372.","journal-title":"JAMA Surg"},{"issue":"8","key":"2258_CR42","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1002\/bjs.9838","volume":"102","author":"DP Howard","year":"2015","unstructured":"Howard DP, Banerjee A, Fairhead JF, et al. Age-specific incidence, risk factors and outcome of acute abdominal aortic aneurysms in a defined population. Br J Surg. 2015;102(8):907\u201315.","journal-title":"Br J Surg"},{"issue":"11","key":"2258_CR43","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1080\/14740338.2019.1665022","volume":"18","author":"AC Bennett","year":"2019","unstructured":"Bennett AC, Bennett CL, Witherspoon BJ, et al. An evaluation of reports of ciprofloxacin, levofloxacin, and moxifloxacin-association neuropsychiatric toxicities, long-term disability, and aortic aneurysms\/dissections disseminated by the Food and Drug Administration and the European Medicines Agency. Expert Opin Drug Saf. 2019;18(11):1055\u201363.","journal-title":"Expert Opin Drug Saf"},{"issue":"3","key":"2258_CR44","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.jacc.2018.09.091","volume":"73","author":"C Dolladille","year":"2019","unstructured":"Dolladille C, Chr\u00e9tien B, Sassier M, et al. Fluoroquinolone and aortic dissection: is it a class effect? J Am Coll Cardiol. 2019;73(3):382\u20133.","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"2258_CR45","doi-asserted-by":"publisher","first-page":"e13331","DOI":"10.1111\/ijcp.13331","volume":"73","author":"L Meng","year":"2019","unstructured":"Meng L, Huang J, Jia Y, Huang H, Qiu F, Sun S. Assessing fluoroquinolone-associated aortic aneurysm and dissection: data mining of the public version of the FDA adverse event reporting system. Int J Clin Pract. 2019;73(5):e13331.","journal-title":"Int J Clin Pract"},{"issue":"4","key":"2258_CR46","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1007\/s11606-018-4774-2","volume":"34","author":"A Sommet","year":"2019","unstructured":"Sommet A, B\u00e9n\u00e9vent J, Rousseau V, et al. What fluoroquinolones have the highest risk of aortic aneurysm? A case\/non-case study in vigiBase\u00ae. Soc Gen Intern Med. 2019;34(4):502\u20133.","journal-title":"Soc Gen Intern Med"},{"issue":"9","key":"2258_CR47","doi-asserted-by":"publisher","first-page":"e181804","DOI":"10.1001\/jamasurg.2018.1804","volume":"153","author":"SA LeMaire","year":"2018","unstructured":"LeMaire SA, Zhang L, Luo W, Ren P, Azares AR, Wang Y, Zhang C, Coselli JS, Shen YH. Effect of ciprofloxacin on susceptibility to aortic dissection and rupture in mice. JAMA Surg. 2018;153(9):e181804.","journal-title":"JAMA Surg"},{"key":"2258_CR48","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1001\/jamainternmed.2020.4199","volume":"180","author":"C Gopalakrishnan","year":"2020","unstructured":"Gopalakrishnan C, Bykov K, Fischer MA, Connolly JG, Gagne JJ, Fralick M. Association of fluoroquinolones with the risk of aortic aneurysm or aortic dissection. JAMA Intern Med. 2020;180:1596\u2013605.","journal-title":"JAMA Intern Med"},{"issue":"15","key":"2258_CR49","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1016\/j.jacc.2021.02.047","volume":"77","author":"SW Chen","year":"2021","unstructured":"Chen SW, Chan YH, Chien-Chia Wu V, et al. Effects of fluoroquinolones on outcomes of patients with aortic dissection or aneurysm. J Am Coll Cardiol. 2021;77(15):1875\u201387.","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"2258_CR50","doi-asserted-by":"publisher","first-page":"e489","DOI":"10.1016\/j.athoracsur.2020.04.044","volume":"110","author":"DG Guzzardi","year":"2020","unstructured":"Guzzardi DG, Hassanabad AF, Bromley AB, et al. Fluoroquinolone-associated type A aortic dissection in alpha-1 anti-trypsin deficiency. Ann Thorac Sur. 2020;110(6):e489\u201391.","journal-title":"Ann Thorac Sur"},{"issue":"12","key":"2258_CR51","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1001\/jamainternmed.2020.4192","volume":"180","author":"YH Dong","year":"2020","unstructured":"Dong YH, Chang CH, Wang JL, et al. Association of infections and use of fluoroquinolones with the risk of aortic aneurysm or aortic dissection. JAMA Intern Med. 2020;180(12):1587\u201395.","journal-title":"JAMA Intern Med"},{"issue":"3","key":"2258_CR52","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1161\/STROKEAHA.119.028490","volume":"51","author":"S Maumus-Robert","year":"2020","unstructured":"Maumus-Robert S, Debette S, B\u00e9rard X, et al. Risk of intracranial aneurysm and dissection and fluoroquinolone use: a case-time-control study. Stroke. 2020;51(3):994\u20137.","journal-title":"Stroke"},{"key":"2258_CR53","first-page":"267215","volume":"2013","author":"M Cury","year":"2013","unstructured":"Cury M, Zeidan F, Lobato AC, et al. Aortic disease in the young: genetic aneurysm syndromes, connective tissue disorders, and familial aortic aneurysms and dissections. Int J Vasc Med. 2013;2013:267215.","journal-title":"Int J Vasc Med"},{"key":"2258_CR54","unstructured":"Bennett A, Qureshi ZP, Bennett CL. A novel genetic marker has been identified in patients with fluoroquinolone-associated neuropyschiatric toxicity: preliminary findings. Federal Pract. 2017;S30."},{"issue":"2","key":"2258_CR55","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1093\/cvr\/cvt089","volume":"99","author":"IE Hoefer","year":"2013","unstructured":"Hoefer IE, den Adel B, Daemen MJ. Biomechanical factors as triggers of vascular growth. Cardiovasc Res. 2013;99(2):276\u201383.","journal-title":"Cardiovasc Res"},{"issue":"1","key":"2258_CR56","doi-asserted-by":"publisher","first-page":"5022","DOI":"10.1038\/s41467-018-07495-1","volume":"9","author":"T Hadi","year":"2018","unstructured":"Hadi T, Boytard L, Silvestro M, Alebrahim D, Jacob S, Feinstein J, Barone K, Spiro W, Hutchison S, Simon R, Rateri D, Pinet F, Fenyo D, Adelman M, Moore KJ, Eltzschig HK, Daugherty A, Ramkhelawon B. Macrophage-derived netrin-1 promotes abdominal aortic aneurysm formation by activating MMP3 in vascular smooth muscle cells. Nat Commun. 2018;9(1):5022.","journal-title":"Nat Commun"},{"issue":"4","key":"2258_CR57","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.ijantimicag.2009.10.009","volume":"35","author":"J Sendzik","year":"2010","unstructured":"Sendzik J, Shakibaei M, Schafer-Korting M, Lode H, Stahlmann R. Synergistic effects of dexamethasone and quinolones on human-derived tendon cells. Int J Antimicrob Agents. 2010;35(4):366\u201374.","journal-title":"Int J Antimicrob Agents"},{"issue":"1","key":"2258_CR58","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1177\/0194599816633671","volume":"155","author":"NC Orobello","year":"2016","unstructured":"Orobello NC, Dirain CO, Schultz G, Milne-Davies BA, Ng MR, Antonelli PJ. Ciprofloxacin decreases collagen in mouse tympanic membrane fibroblasts. Otolaryngol Head Neck Surg Off J Am Acad Otolaryngol Head Neck Surg. 2016;155(1):127\u201332.","journal-title":"Otolaryngol Head Neck Surg Off J Am Acad Otolaryngol Head Neck Surg"},{"issue":"1","key":"2258_CR59","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3109\/15376516.2010.529183","volume":"21","author":"C Sharma","year":"2011","unstructured":"Sharma C, Velpandian T, Baskar Singh S, Ranjan Biswas N, Bihari Vajpayee R, Ghose S. Effect of fluoroquinolones on the expression of matrix metalloproteinase in debrided cornea of rats. Toxicol Mech Methods. 2011;21(1):6\u201312.","journal-title":"Toxicol Mech Methods"},{"issue":"1","key":"2258_CR60","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1002\/jor.21196","volume":"29","author":"WC Tsai","year":"2011","unstructured":"Tsai WC, Hsu CC, Chen CP, Chang HN, Wong AM, Lin MS, Pang JH. Ciprofloxacin up-regulates tendon cells to express matrix metalloproteinase-2 with degradation of type I collagen. J Orthop Res Off Publ Orthop Res Soc. 2011;29(1):67\u201373.","journal-title":"J Orthop Res Off Publ Orthop Res Soc"},{"issue":"6","key":"2258_CR61","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.3892\/ijmm.2012.1150","volume":"30","author":"AM Bujor","year":"2012","unstructured":"Bujor AM, Haines P, Padilla C, Christmann RB, Junie M, Sampaio-Barros PD, Lafyatis R, Trojanowska M. Ciprofloxacin has antifibrotic effects in scleroderma fibroblasts via downregulation of Dnmt1 and upregulation of Fli1. Int J Mol Med. 2012;30(6):1473\u201380.","journal-title":"Int J Mol Med"},{"key":"2258_CR62","first-page":"58","volume":"1","author":"D Wang","year":"2014","unstructured":"Wang D, Jahangir A, Tajik JK. Ciprofloxacin enhances matrix metalloproteinases activity in human ASMCs. J Patient-Centered Res Rev. 2014;1:58\u20139.","journal-title":"J Patient-Centered Res Rev"},{"key":"2258_CR63","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.cjca.2017.07.092","volume":"33","author":"D Guzzardi","year":"2017","unstructured":"Guzzardi D, Teng G, Svystonyuk D. Fluoroquinolone induces human aortic fibroblast mediated extracellular matrix dysregulation. Can J Cardiol. 2017;33:38\u20139.","journal-title":"Can J Cardiol"},{"issue":"1","key":"2258_CR64","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.jtcvs.2018.08.079","volume":"157","author":"DG Guzzardi","year":"2019","unstructured":"Guzzardi DG, Teng G, Kang S, Geeraert PJ, Pattar SS, Svystonyuk DA, Belke DD, Fedak PWM. Induction of human aortic myofibroblast-mediated extracellular matrix dysregulation: a potential mechanism of fluoroquinolone-associated aortopathy. J Thorac Cardiovasc Surg. 2019;157(1):109-19e2.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"36","key":"2258_CR65","doi-asserted-by":"publisher","first-page":"22287","DOI":"10.1074\/jbc.M115.671222","volume":"290","author":"S Badal","year":"2015","unstructured":"Badal S, Her YF, Maher LJ 3rd. Nonantibiotic effects of fluoroquinolones in mammalian cells. J Biol Chem. 2015;290(36):22287\u201397.","journal-title":"J Biol Chem"},{"issue":"2","key":"2258_CR66","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1128\/AAC.44.2.261-266.2000","volume":"44","author":"M Shakibaei","year":"2000","unstructured":"Shakibaei M, Pfister K, Schwabe R, Vormann J, Stahlmann R. Ultrastructure of Achilles tendons of rats treated with ofloxacin and fed a normal or magnesium-deficient diet. Antimicrob Agents Chemother. 2000;44(2):261\u20136.","journal-title":"Antimicrob Agents Chemother"},{"issue":"10\u201311","key":"2258_CR67","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/s002040050010","volume":"73","author":"R Stahlmann","year":"2000","unstructured":"Stahlmann R, Kuhner S, Shakibaei M, Flores J, Vormann J, van Sickle DC. Effects of magnesium deficiency on joint cartilage in immature beagle dogs: immunohistochemistry, electron microscopy, and mineral concentrations. Arch Toxicol. 2000;73(10\u201311):573\u201380.","journal-title":"Arch Toxicol"},{"issue":"1\u20133","key":"2258_CR68","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.ejphar.2009.02.006","volume":"607","author":"WC Tsai","year":"2009","unstructured":"Tsai WC, Hsu CC, Chen HC, Hsu YH, Lin MS, Wu CW, Pang JH. Ciprofloxacin-mediated inhibition of tenocyte migration and down-regulation of focal adhesion kinase phosphorylation. Eur J Pharmacol. 2009;607(1\u20133):23\u20136.","journal-title":"Eur J Pharmacol"},{"issue":"10","key":"2258_CR69","first-page":"1262","volume":"25","author":"P Li","year":"2004","unstructured":"Li P, Cheng NN, Chen BY, Wang YM. In vivo and in vitro chondrotoxicity of ciprofloxacin in juvenile rats. Acta Pharmacol Sin. 2004;25(10):1262\u20136.","journal-title":"Acta Pharmacol Sin"},{"issue":"3","key":"2258_CR70","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1177\/03635465000280031401","volume":"28","author":"RJ Williams 3rd","year":"2000","unstructured":"Williams RJ 3rd, Attia E, Wickiewicz TL, Hannafin JA. The effect of ciprofloxacin on tendon, paratenon, and capsular fibroblast metabolism. Am J Sports Med. 2000;28(3):364\u20139.","journal-title":"Am J Sports Med"},{"issue":"4","key":"2258_CR71","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1111\/j.1751-1097.2010.00755.x","volume":"86","author":"B Zhao","year":"2010","unstructured":"Zhao B, Chignell CF, Rammal M, Smith F, Hamilton MG, Andley UP, Roberts JE. Detection and prevention of ocular phototoxicity of ciprofloxacin and other fluoroquinolone antibiotics. Photochem Photobiol. 2010;86(4):798\u2013805.","journal-title":"Photochem Photobiol"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-021-02258-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-021-02258-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-021-02258-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,9]],"date-time":"2023-11-09T16:15:51Z","timestamp":1699546551000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-021-02258-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,28]]},"references-count":71,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["2258"],"URL":"https:\/\/doi.org\/10.1186\/s12872-021-02258-1","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,28]]},"assertion":[{"value":"20 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no conflict of interest that are directly relevant to the content of this article.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"470"}}